SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001683168-22-007347
Filing Date
2022-11-07
Accepted
2022-11-07 14:17:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 5 lisapharma_13g.htm SC 13G/A 37167
  Complete submission text file 0001683168-22-007347.txt   38733
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Subject) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91807 | Film No.: 221364966
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 470 MOHAWK CIRCLE STOYSTOWN PA 15563
Business Address 470 MOHAWK CIRCLE STOYSTOWN PA 15563 814-754-3240
Lisa Pharma, LLC (Filed by) CIK: 0001846892 (see all company filings)

IRS No.: 831600437 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A